TD Cowen Cuts Clorox (NYSE:CLX) Price Target to $108.00

Clorox (NYSE:CLX) had its price objective cut by TD Cowen from $117.00 to $108.00 in a research note released on Thursday,Benzinga reports. They currently have a hold rating on the stock.

Several other brokerages have also recently commented on CLX. Citigroup dropped their target price on shares of Clorox from $120.00 to $109.00 and set a “neutral” rating for the company in a research report on Wednesday, December 17th. Cowen restated a “hold” rating on shares of Clorox in a research report on Thursday. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. Rothschild & Co Redburn lowered their price target on Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 14th. One analyst has rated the stock with a Buy rating, fourteen have assigned a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Reduce” and a consensus price target of $122.88.

Clorox Price Performance

Shares of NYSE CLX opened at $106.20 on Thursday. The business has a fifty day moving average price of $103.00 and a two-hundred day moving average price of $115.62. The stock has a market capitalization of $12.95 billion, a PE ratio of 16.67, a P/E/G ratio of 0.53 and a beta of 0.58. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50. Clorox has a fifty-two week low of $96.66 and a fifty-two week high of $164.22.

Clorox (NYSE:CLX) last released its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.07. The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. Clorox had a return on equity of 358.39% and a net margin of 11.68%.Clorox’s quarterly revenue was down 18.9% on a year-over-year basis. During the same period in the prior year, the firm posted $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities analysts predict that Clorox will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be given a $1.24 dividend. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 annualized dividend and a yield of 4.7%. Clorox’s dividend payout ratio (DPR) is currently 77.86%.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber acquired 4,000 shares of the stock in a transaction dated Friday, November 21st. The stock was bought at an average price of $104.13 per share, with a total value of $416,520.00. Following the completion of the purchase, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. This represents a 44.44% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.63% of the company’s stock.

Institutional Investors Weigh In On Clorox

Several hedge funds have recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Clorox by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after acquiring an additional 514 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in Clorox by 147.6% in the first quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company’s stock valued at $104,107,000 after purchasing an additional 421,453 shares during the period. Caxton Associates LLP bought a new position in Clorox during the 1st quarter worth $580,000. Empowered Funds LLC lifted its holdings in Clorox by 109.9% during the 1st quarter. Empowered Funds LLC now owns 46,534 shares of the company’s stock worth $6,852,000 after buying an additional 24,360 shares during the period. Finally, Woodline Partners LP grew its position in shares of Clorox by 253.7% in the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after buying an additional 7,465 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.